Iqvia Holdings (IQV) Other Non-Current Liabilities (2012 - 2026)
Iqvia Holdings (IQV) posted Other Non-Current Liabilities of $645.0 million for Q2 2026, up 4.54% sequentially from $617.0 million in Q1 2026, and down 3.87% YoY from $671.0 million in Q2 2025.
Iqvia Holdings (IQV) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends
Iqvia Holdings has reported Other Non-Current Liabilities for 15 years, with the latest figure at $645.0 million in Q2 2026.
- Quarterly Other Non-Current Liabilities fell 3.87% year-over-year to $645.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $645.0 million (down 3.87% YoY) and the FY2025 annual result came in at $688.0 million, up 2.99% from the prior year.
- Other Non-Current Liabilities grew to $645.0 million in Q2 2026 per IQV's latest filing, from $617.0 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $703.0 million in Q2 2023 and troughed at $173.0 million in Q4 2022.
- A 5-year average of $616.7 million and a median of $643.0 million in 2023 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities soared 554.65% in 2022, then decreased 10.1% in 2024.
- Over 5 years, Other Non-Current Liabilities stood at $173.0 million in 2022, then soared by 303.47% to $698.0 million in 2023, then dropped by 4.3% to $668.0 million in 2024, then grew by 2.99% to $688.0 million in 2025, then dropped by 6.25% to $645.0 million in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $645.0 million, $617.0 million, and $688.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 645.00 Mn |
| Mar 31, 2026 | 617.00 Mn |
| Dec 31, 2025 | 688.00 Mn |
| Sep 30, 2025 | 698.00 Mn |
| Jun 30, 2025 | 671.00 Mn |
| Mar 31, 2025 | 676.00 Mn |
| Dec 31, 2024 | 668.00 Mn |
| Sep 30, 2024 | 612.00 Mn |
| Jun 30, 2024 | 632.00 Mn |
| Mar 31, 2024 | 595.00 Mn |
| Dec 31, 2023 | 698.00 Mn |
| Sep 30, 2023 | 679.00 Mn |
| Jun 30, 2023 | 703.00 Mn |
| Mar 31, 2023 | 641.00 Mn |
| Dec 31, 2022 | 173.00 Mn |
| Sep 30, 2022 | 561.00 Mn |
| Jun 30, 2022 | 563.00 Mn |
| Mar 31, 2022 | 581.00 Mn |
| Dec 31, 2021 | 76.00 Mn |
| Sep 30, 2021 | 96.00 Mn |